• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织转谷氨酰胺酶诱导大肠癌细胞发生上皮-间质转化并获得干细胞样特征。

Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.

作者信息

Ayinde Oluseyi, Wang Zhuo, Griffin Martin

机构信息

School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham B4 7ET, United Kingdom.

出版信息

Oncotarget. 2017 Mar 21;8(12):20025-20041. doi: 10.18632/oncotarget.15370.

DOI:10.18632/oncotarget.15370
PMID:28223538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5386741/
Abstract

Human colon cancer cell lines (CRCs) RKO, SW480 and SW620 were investigated for TG2 involvement in tumour advancement and aggression. TG2 expression correlated with tumour advancement and expression of markers of epithelial-mesenchymal transition (EMT). The metastatic cell line SW620 showed high TG2 expression compared to the primary tumour cell lines SW480 and RKO and could form tumour spheroids under non- adherent conditions. TG2 manipulation in the CRCs by shRNA or TG2 transduction confirmed the relationship between TG2 and EMT. TGFβ1 expression in CRC cells, and its level in the cell medium and extracellular matrix was increased in primary tumour CRCs overexpressing TG2 and could regulate TG2 expression and EMT by both canonical (RKO) and non-canonical (RKO and SW480) signalling. TGFβ1 regulation was not observed in the metastatic SW620 cell line, but TG2 knockdown or inhibition in SW620 reversed EMT. In SW620, TG2 expression and EMT was associated with increased presence of nuclear β-catenin which could be mediated by association of TG2 with the Wnt signalling co-receptor LRP5. TG2 inhibition/knockdown increased interaction between β-catenin and ubiquitin shown by co-immunoprecipitation, suggesting that TG2 could be important in β-catenin regulation. β-Catenin and TG2 was also upregulated in SW620 spheroid cells enriched with cancer stem cell marker CD44 and TG2 inhibition/knockdown reduced the spheroid forming potential of SW620 cells. Our data suggests that TG2 could hold both prognostic and therapeutic significance in colon cancer.

摘要

研究了人结肠癌细胞系(CRC)RKO、SW480和SW620中组织转谷氨酰胺酶2(TG2)在肿瘤进展和侵袭中的作用。TG2表达与肿瘤进展以及上皮-间质转化(EMT)标志物的表达相关。与原发性肿瘤细胞系SW480和RKO相比,转移性细胞系SW620显示出高TG2表达,并且在非贴壁条件下能够形成肿瘤球。通过短发夹RNA(shRNA)或TG2转导对CRC中的TG2进行调控,证实了TG2与EMT之间的关系。在过表达TG2的原发性肿瘤CRC中,CRC细胞中转化生长因子β1(TGFβ1)的表达及其在细胞培养基和细胞外基质中的水平升高,并且可以通过经典信号通路(RKO)和非经典信号通路(RKO和SW480)调节TG2表达和EMT。在转移性SW620细胞系中未观察到TGFβ1调节作用,但在SW620中敲低或抑制TG2可逆转EMT。在SW620中,TG2表达和EMT与核β-连环蛋白的增加有关,这可能是由TG2与Wnt信号共受体低密度脂蛋白受体相关蛋白5(LRP5)的结合介导的。共免疫沉淀显示,TG2抑制/敲低增加了β-连环蛋白与泛素之间的相互作用,表明TG2在β-连环蛋白调节中可能很重要。在富含癌症干细胞标志物CD44的SW620球状体细胞中,β-连环蛋白和TG2也上调,并且TG2抑制/敲低降低了SW620细胞形成球状体的潜力。我们的数据表明,TG2在结肠癌中可能具有预后和治疗意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/7f169512247a/oncotarget-08-20025-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/6f7dccaf68d3/oncotarget-08-20025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/f0db63df7356/oncotarget-08-20025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/3e899cca28a7/oncotarget-08-20025-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/4c2020fa17c3/oncotarget-08-20025-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/0f775e3386b1/oncotarget-08-20025-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/8708243b8a08/oncotarget-08-20025-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/fb64ecda7431/oncotarget-08-20025-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/7f169512247a/oncotarget-08-20025-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/6f7dccaf68d3/oncotarget-08-20025-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/f0db63df7356/oncotarget-08-20025-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/3e899cca28a7/oncotarget-08-20025-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/4c2020fa17c3/oncotarget-08-20025-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/0f775e3386b1/oncotarget-08-20025-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/8708243b8a08/oncotarget-08-20025-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/fb64ecda7431/oncotarget-08-20025-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba45/5386741/7f169512247a/oncotarget-08-20025-g008.jpg

相似文献

1
Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.组织转谷氨酰胺酶诱导大肠癌细胞发生上皮-间质转化并获得干细胞样特征。
Oncotarget. 2017 Mar 21;8(12):20025-20041. doi: 10.18632/oncotarget.15370.
2
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.II型转谷氨酰胺酶刺激表皮癌干细胞上皮-间质转化。
Oncotarget. 2015 Aug 21;6(24):20525-39. doi: 10.18632/oncotarget.3890.
3
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.PARP3通过刺激转谷氨酰胺酶2-蜗牛-E-钙黏蛋白轴来控制转化生长因子β和活性氧驱动的上皮-间质转化及干性。
Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
4
Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.组织转谷氨酰胺酶调节卵巢癌干细胞与肿瘤微环境之间的相互作用。
Cancer Res. 2018 Jun 1;78(11):2990-3001. doi: 10.1158/0008-5472.CAN-17-2319. Epub 2018 Mar 6.
5
OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.OVOL2,一种 WNT 信号通路的抑制剂,降低了人源和鼠源癌细胞的侵袭活性,并且在人结直肠肿瘤中下调。
Gastroenterology. 2016 Mar;150(3):659-671.e16. doi: 10.1053/j.gastro.2015.11.041. Epub 2015 Nov 24.
6
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition.转谷氨酰胺酶2通过调节上皮-间质转化维持结直肠癌干细胞表型。
Oncotarget. 2019 Jul 16;10(44):4556-4569. doi: 10.18632/oncotarget.27062.
7
IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.IWR-1通过抑制Wnt/β-连环蛋白信号通路以及survivin表达来抑制结肠癌细胞的上皮-间质转化。
Oncotarget. 2015 Sep 29;6(29):27146-59. doi: 10.18632/oncotarget.4354.
8
Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.转谷氨酰胺酶 2 通过下调蛋白磷酸酶 2A 激活 c-Jun-N 端激酶诱导 TGF-β1 诱导的上皮间质转化中 N 钙粘蛋白的表达。
Eur J Cancer. 2013 May;49(7):1692-705. doi: 10.1016/j.ejca.2012.11.036. Epub 2013 Jan 2.
9
Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.证据表明,转谷氨酰胺酶 2 的 GTP 结合结构域而非催化结构域对于乳腺上皮细胞中的上皮-间充质转化是必需的。
Breast Cancer Res. 2012 Jan 6;14(1):R4. doi: 10.1186/bcr3085.
10
Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.miR-147 的异位表达抑制结肠癌细胞中干细胞标志物和上皮-间充质转化(EMT)相关蛋白的表达。
Oncol Res. 2019 Mar 29;27(4):399-406. doi: 10.3727/096504018X15179675206495. Epub 2018 Feb 9.

引用本文的文献

1
Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment.转谷氨酰胺酶2通过调节免疫微环境来调控卵巢癌转移。
Front Immunol. 2025 Jul 24;16:1639853. doi: 10.3389/fimmu.2025.1639853. eCollection 2025.
2
Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.转谷氨酰胺酶2刺激肝癌细胞增殖并独立于上皮-间质转化调节转化生长因子-β信号通路。
Int J Mol Sci. 2025 Jun 8;26(12):5497. doi: 10.3390/ijms26125497.
3
Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model.

本文引用的文献

1
Prognostic role of tissue transglutaminase 2 in colon carcinoma.组织转谷氨酰胺酶2在结肠癌中的预后作用
Virchows Arch. 2016 Dec;469(6):611-619. doi: 10.1007/s00428-016-2020-z. Epub 2016 Sep 13.
2
A novel regulatory role for tissue transglutaminase in epithelial-mesenchymal transition in cystic fibrosis.组织转谷氨酰胺酶在囊性纤维化上皮-间质转化中的新调控作用。
Biochim Biophys Acta. 2016 Sep;1863(9):2234-44. doi: 10.1016/j.bbamcr.2016.05.012. Epub 2016 May 24.
3
A Small-Molecule Antagonist of the β-Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis.
在博来霉素小鼠模型中,选择性小分子抑制剂对转谷氨酰胺酶2的抑制作用可减轻纤维化并改善肺功能。
Cells. 2025 Mar 26;14(7):497. doi: 10.3390/cells14070497.
4
Shaping Oncogenic Microenvironments: Contribution of Fibronectin.塑造致癌微环境:纤连蛋白的作用
Front Cell Dev Biol. 2024 Apr 10;12:1363004. doi: 10.3389/fcell.2024.1363004. eCollection 2024.
5
Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2.三种斑马鱼转谷氨酰胺酶2的生化与功能特性
Int J Mol Sci. 2023 Jul 27;24(15):12041. doi: 10.3390/ijms241512041.
6
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model.缺氧相关预后模型的生物信息学分析与实验验证。
J Gastrointest Oncol. 2023 Jun 30;14(3):1504-1524. doi: 10.21037/jgo-23-301. Epub 2023 Jun 19.
7
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.用无环维甲酸靶向肝癌干细胞中的转谷氨酰胺酶 2 介导的外生粘蛋白糖基转移酶 1 信号通路。
Cell Death Dis. 2023 Jun 13;14(6):358. doi: 10.1038/s41419-023-05847-4.
8
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype.转谷氨酰胺酶 2 肿瘤细胞生存因子维持 mTOR 活性以驱动侵袭性癌症表型。
Mol Carcinog. 2023 Jan;62(1):90-100. doi: 10.1002/mc.23446. Epub 2022 Jul 18.
9
The Outside-In Journey of Tissue Transglutaminase in Cancer.组织转谷氨酰胺酶在癌症中的外向旅程。
Cells. 2022 May 29;11(11):1779. doi: 10.3390/cells11111779.
10
Inactivation of Wnt-LRP5 signaling suppresses the proliferation and migration of ovarian cancer cells.Wnt-LRP5信号通路的失活抑制卵巢癌细胞的增殖和迁移。
Transl Cancer Res. 2021 May;10(5):2277-2285. doi: 10.21037/tcr-20-3462.
小分子 β-联蛋白/TCF4 相互作用拮抗剂阻断癌症干细胞的自我更新并抑制肿瘤发生。
Cancer Res. 2016 Feb 15;76(4):891-901. doi: 10.1158/0008-5472.CAN-15-1519. Epub 2015 Dec 8.
4
Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.强效和选择性组织转谷氨酰胺酶抑制剂的研发:它们对TG2功能的影响及其在病理状况中的应用
Chem Biol. 2015 Oct 22;22(10):1347-61. doi: 10.1016/j.chembiol.2015.08.013. Epub 2015 Oct 9.
5
Transglutaminase 2--a novel inhibitor of adipogenesis.转谷氨酰胺酶2——一种新型脂肪生成抑制剂。
Cell Death Dis. 2015 Aug 27;6(8):e1868. doi: 10.1038/cddis.2015.238.
6
Type II transglutaminase stimulates epidermal cancer stem cell epithelial-mesenchymal transition.II型转谷氨酰胺酶刺激表皮癌干细胞上皮-间质转化。
Oncotarget. 2015 Aug 21;6(24):20525-39. doi: 10.18632/oncotarget.3890.
7
STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.基质相互作用分子1(STIM1)是微小RNA - 185的直接靶点,可促进肿瘤转移,且与结直肠癌的不良预后相关。
Oncogene. 2015 Sep 10;34(37):4808-20. doi: 10.1038/onc.2014.404. Epub 2014 Dec 22.
8
Targeting the TGFβ pathway for cancer therapy.针对癌症治疗的 TGFβ 通路。
Pharmacol Ther. 2015 Mar;147:22-31. doi: 10.1016/j.pharmthera.2014.11.001. Epub 2014 Nov 6.
9
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.Wnt/β-catenin 信号通路通过激活 Oct4 来维持头颈部鳞状细胞癌干细胞样细胞的自我更新和致瘤性。
J Pathol. 2014 Sep;234(1):99-107. doi: 10.1002/path.4383. Epub 2014 Jul 23.
10
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer.结直肠癌细胞系是主要原发性癌症分子亚型的代表性模型。
Cancer Res. 2014 Jun 15;74(12):3238-47. doi: 10.1158/0008-5472.CAN-14-0013. Epub 2014 Apr 22.